- Home
- ARWR vs XP Comparison
ARWR vs XP Comparison
Compare ARWR & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | XP |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.3B |
| IPO Year | 2009 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARWR | XP |
|---|---|---|
| Price | $74.25 | $16.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $83.40 | $23.17 |
| AVG Volume (30 Days) | 2.0M | ★ 5.8M |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $19.00 |
| Revenue Next Year | N/A | $13.64 |
| P/E Ratio | ★ N/A | $11.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.01 | $14.80 |
| 52 Week High | $87.83 | $23.13 |
Technical Indicators
Market Signals| Indicator | ARWR | XP |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 54.42 |
| Support Level | $70.05 | $16.25 |
| Resistance Level | $77.39 | $17.18 |
| Average True Range (ATR) | 3.85 | 0.56 |
| MACD | -1.15 | 0.11 |
| Stochastic Oscillator | 24.35 | 81.28 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.